Andere talen Valneva Xetra

Aandelen

AYJ

FR0004056851

Beurs gesloten - Xetra Andere beurzen 17:35:37 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,112 ^EUR	+2,24%		+5,33%	-13,41%

31/05	Valneva's Chikungunya-vaccin krijgt steun van EU-regelgevend comité	MT
31/05	EU-regulator beveelt gebruik van Valneva's chikungunya-vaccin aan	RE

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Valneva's Chikungunya Vaccine Gains Support From EU Regulator Committee	31/05
EU regulator recommends use of Valneva's chikungunya vaccine	31/05
Valneva Se Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer	22/05
Valneva Names New Chief Scientific Officer	21/05
Valneva SE Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Transcript : Valneva SE, Q1 2024 Earnings Call, May 07, 2024	07/05
Valneva SE Confirms Earnings Guidance for the Fiscal Year 2024	07/05
Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate	26/03
Valneva SE Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate	26/03
Valneva SE Raises Revenue Guidance for 2024	20/03
Valneva SE Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
Transcript : Valneva SE, 2023 Earnings Call, Mar 20, 2024	20/03
French biotech company Valneva raises product sales guidance	20/03
Valneva Secures 18-month Extension to Interest-only Period for US Debt Facility	18/03
U.S. CDC Advisory Committee Recommends Use of Valneva?s Single-Dose Chikungunya Vaccine IXCHIQ	29/02
US Centers for Disease Control's Committee Recommends Valneva's Chikungunya Virus Vaccine	29/02
Valneva Se Announces Earnings Guidance for 2024	15/02
Valneva Sells Tropical Disease Priority Review Voucher for $103 Million	05/02
Valneva Sells Chikungunya Virus Vaccine’s Priority Review Voucher for $103 Million	05/02
Valneva Se Announces the First Participant Has Been Vaccinated in the Phase 2 Clinical Trial Evaluating the Safety and Immunogenicity in Children of Two Different Dose Levels of Valneva?S Single-Shot Chikungunya Vaccine	10/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Valneva Xetra

Aandelen

AYJ

FR0004056851

Andere talen

Filters